Literature DB >> 16478952

Performance, diarrhea incidence, and occurrence of Escherichia coli virulence genes during long-term administration of a probiotic Enterococcus faecium strain to sows and piglets.

D Taras1, W Vahjen, M Macha, O Simon.   

Abstract

As part of an interdisciplinary research project, the performance response of sows and their litters to the probiotic strain Enterococcus faecium NCIMB 10415, as well as some health characteristics of the piglets, were studied. Gestating sows (n = 26) were randomly allotted into 2 groups. The probiotic was administered by dietary supplementation to 1 group of sows and their respective litters (probiotic group), whereas the second group (control group) received no probiotic supplementation. The duration of the treatment was nearly 17 wk for sows (d 90 ante partum until d 28 postpartum) and 6 wk for piglets (d 15 to 56). Body weight and feed consumption were recorded weekly. The frequency of 4 toxin and 5 adhesion genes of putative pathogenic Escherichia coli was monitored weekly (d 7 to 35) by multiplex PCR assays, and fecal consistency of weaned piglets was studied daily. Probiotic treatment of lactating sows led to an overall pre-weaning mortality of 16.2% compared with 22.3% in the control group (P = 0.44). Animal losses during the first 3 d of the suckling period were decreased in the probiotic group (P = 0.09). For piglets (n = 153), which were weaned at 28 d, there were no overall treatment differences in BW gain, feed intake, or feed efficiency. Probiotic supplementation, however, led to nearly a 40% reduction (P = 0.012). The actual percentage of piglets with postweaning diarrhea in the probiotic group was 21% compared with 38% in the control group (P = 0.05). The study on virulence factors of dominant fecal E. coli isolates revealed a high diversity with varying frequency and distribution of each single pathogenicity gene. The 440 isolates carried 29 different pathogenicity gene combinations as well as each of the 9 pathogenicity genes alone. Altogether, isolates with more than 2 pathogenicity genes were quite rare (< or = 10%), and up until d 28 isolates without any pathogenicity gene occurred most frequently. Depending on the time of sampling, one-third or more of all isolates contained est2 or est1b as single gene or in combination with other pathogenicity genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478952     DOI: 10.2527/2006.843608x

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  35 in total

1.  Feeding the probiotic Enterococcus faecium strain NCIMB 10415 to piglets specifically reduces the number of Escherichia coli pathotypes that adhere to the gut mucosa.

Authors:  Carmen Bednorz; Sebastian Guenther; Kathrin Oelgeschläger; Bianca Kinnemann; Robert Pieper; Susanne Hartmann; Karsten Tedin; Torsten Semmler; Konrad Neumann; Peter Schierack; Astrid Bethe; Lothar H Wieler
Journal:  Appl Environ Microbiol       Date:  2013-10-11       Impact factor: 4.792

2.  Enterococci from piglets--probiotic properties and responsiveness to natural antibacterial substances.

Authors:  V Strompfová; A Lauková
Journal:  Folia Microbiol (Praha)       Date:  2010-02-07       Impact factor: 2.099

3.  Effects of Ex Vivo Infection with ETEC on Jejunal Barrier Properties and Cytokine Expression in Probiotic-Supplemented Pigs.

Authors:  Ulrike Lodemann; Salah Amasheh; Judith Radloff; Martina Kern; Astrid Bethe; Lothar H Wieler; Robert Pieper; Jürgen Zentek; Jörg R Aschenbach
Journal:  Dig Dis Sci       Date:  2016-12-19       Impact factor: 3.199

4.  No beneficial effects evident for Enterococcus faecium NCIMB 10415 in weaned pigs infected with Salmonella enterica serovar Typhimurium DT104.

Authors:  Susanne Kreuzer; Pawel Janczyk; Jens Assmus; Michael F G Schmidt; Gudrun A Brockmann; Karsten Nöckler
Journal:  Appl Environ Microbiol       Date:  2012-04-27       Impact factor: 4.792

5.  Whole genome sequence analyses-based assessment of virulence potential and antimicrobial susceptibilities and resistance of Enterococcus faecium strains isolated from commercial swine and cattle probiotic products.

Authors:  Pragathi B Shridhar; Raghavendra G Amachawadi; Mike Tokach; Isha Patel; Jayanthi Gangiredla; Mark Mammel; T G Nagaraja
Journal:  J Anim Sci       Date:  2022-03-01       Impact factor: 3.159

6.  Influence of a probiotic strain of Enterococcus faecium on Salmonella enterica serovar Typhimurium DT104 infection in a porcine animal infection model.

Authors:  István Szabó; Lothar H Wieler; Karsten Tedin; Lydia Scharek-Tedin; David Taras; Andreas Hensel; Bernd Appel; Karsten Nöckler
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

7.  Isolation and characterization of intestinal Escherichia coli clones from wild boars in Germany.

Authors:  Peter Schierack; Antje Römer; Jörg Jores; Heike Kaspar; Sebastian Guenther; Matthias Filter; Jürgen Eichberg; Lothar H Wieler
Journal:  Appl Environ Microbiol       Date:  2008-12-05       Impact factor: 4.792

8.  Use of Lactobacillus plantarum (strains 22F and 25F) and Pediococcus acidilactici (strain 72N) as replacements for antibiotic-growth promotants in pigs.

Authors:  Pawiya Pupa; Prasert Apiwatsiri; Wandee Sirichokchatchawan; Nopadon Pirarat; Tanawong Maison; Anantawat Koontanatechanon; Nuvee Prapasarakul
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

9.  Effects of liquid metabolite combinations produced by Lactobacillus plantarum on growth performance, faeces characteristics, intestinal morphology and diarrhoea incidence in postweaning piglets.

Authors:  T V Thu; Teck Chwen Loh; H L Foo; H Yaakub; M H Bejo
Journal:  Trop Anim Health Prod       Date:  2010-07-15       Impact factor: 1.559

10.  Dietary Supplementation with Enterococcus faecium R1 Attenuates Intestinal and Liver Injury in Piglets Challenged by Lipopolysaccharide.

Authors:  Yanyan Zhang; Tao Wu; Zhenqiang Chen; Yuxuan Meng; Zhekun Zhu; Qian Wang; Junjie Tian; Dan Yi; Lei Wang; Di Zhao; Yongqing Hou
Journal:  Animals (Basel)       Date:  2021-05-16       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.